Tetroxoprim: Difference between revisions
Appearance
Content deleted Content added
No edit summary |
Entranced98 (talk | contribs) Importing Wikidata short description: "Chemical compound" |
||
(34 intermediate revisions by 19 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} |
|||
{{refimprove|date=August 2014}} |
|||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = changed |
|||
⚫ | |||
| Watchedfields = changed |
|||
⚫ | |||
| verifiedrevid = 408927686 |
|||
⚫ | |||
⚫ | |||
| CAS_supplemental = |
|||
⚫ | |||
⚫ | |||
⚫ | |||
<!--Clinical data--> |
|||
⚫ | |||
| tradename = |
|||
⚫ | |||
| |
| |
||
⚫ | |||
⚫ | |||
| |
| = |
||
⚫ | |||
⚫ | |||
⚫ | |||
| molecular_weight = 334.70 g/mol |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| |
| = |
||
⚫ | |||
⚫ | |||
<!--Pharmacokinetic data--> |
|||
⚫ | |||
| protein_bound = |
|||
⚫ | |||
| elimination_half-life = |
| elimination_half-life = |
||
| excretion |
| excretion = |
||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
|||
<!--Identifiers--> |
|||
⚫ | |||
| CAS_number_Ref = {{cascite|correct|??}} |
|||
| pregnancy_category= |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| legal_status = |
|||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|||
⚫ | |||
| DrugBank = |
|||
| UNII_Ref = {{fdacite|changed|FDA}} |
|||
| UNII = 5R6712AY0K |
|||
| KEGG_Ref = {{keggcite|correct|kegg}} |
|||
⚫ | |||
| ChEMBL_Ref = {{ebicite|changed|EBI}} |
|||
| ChEMBL = 32039 |
|||
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
|||
| ChemSpiderID = 58910 |
|||
<!--Chemical data--> |
|||
| chemical_formula = |
|||
⚫ | |||
⚫ | |||
| StdInChI_Ref = {{stdinchicite|changed|chemspider}} |
|||
| StdInChI = 1S/C16H22N4O4/c1-21-4-5-24-14-12(22-2)7-10(8-13(14)23-3)6-11-9-19-16(18)20-15(11)17/h7-9H,4-6H2,1-3H3,(H4,17,18,19,20) |
|||
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}} |
|||
| StdInChIKey = WSWJIZXMAUYHOE-UHFFFAOYSA-N |
|||
}} |
}} |
||
'''Tetroxoprim''' ([[International Nonproprietary Name|INN]]) is a derivative of [[trimethoprim]]. It was first described in 1979.<ref>{{cite journal | |
'''Tetroxoprim''' ([[International Nonproprietary Name|INN]]) is a derivative of [[trimethoprim]]. It was first described in 1979.<ref>{{cite journal |=Aschhoff HS, Vergin H |title=Tetroxoprim—a new inhibitor of bacterial dihydrofolate reductase |journal=J Antimicrob Chemother |volume=5 |issue=B |pages=19–25 |=1979 |pmid=43863 |doi= }}</ref> |
||
Its chemical formula is C=16 | H=22 | N=4 | O=4. <ref name="auto">{{Cite web|url=https://pubchem.ncbi.nlm.nih.gov/compound/65450|title=Tetroxoprim|website=pubchem.ncbi.nlm.nih.gov}}</ref><ref name="auto1">{{Cite web|url=https://www.sciencedirect.com/topics/nursing-and-health-professions/tetroxoprim|title=Tetroxoprim - an overview | ScienceDirect Topics|website=www.sciencedirect.com}}</ref> |
|||
==References== |
==References== |
||
{{Reflist}} |
{{Reflist}} |
||
⚫ | |||
{{Sulfonamides and trimethoprim}} |
{{Sulfonamides and trimethoprim}} |
||
[[Category: |
[[Category: reductase inhibitors]] |
||
[[Category: |
[[Category:]] |
||
[[Category:Phenol ethers]] |
[[Category:Phenol ethers]] |
||
⚫ |